Stefan Pilz

Author PubWeight™ 111.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008 7.21
2 EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012 3.97
3 Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 2013 2.87
4 Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013 2.73
5 Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 2010 2.64
6 Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012 2.43
7 Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010 2.38
8 The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degeneration. Ophthalmology 2012 2.30
9 Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2011 2.16
10 Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol 2010 2.13
11 Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J 2010 1.82
12 Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J 2010 1.72
13 Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure. Eur Heart J 2011 1.55
14 Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2010 1.46
15 Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Atherosclerosis 2013 1.46
16 Vitamin D deficiency contributed to Mozart's death. Med Probl Perform Art 2011 1.38
17 Associations of daytime, nighttime, and 24-hour heart rate with four distinct markers of inflammation in hypertensive patients: the Styrian Hypertension Study. J Clin Hypertens (Greenwich) 2014 1.38
18 Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008 1.37
19 Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur Heart J 2010 1.30
20 Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results. Ophthalmology 2012 1.26
21 Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 2010 1.19
22 Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study. Ophthalmology 2012 1.19
23 Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res 2012 1.14
24 Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol 2011 1.13
25 The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev 2011 1.09
26 Evidence of a synergistic association between heart rate, inflammation, and cardiovascular mortality in patients undergoing coronary angiography. Eur Heart J 2012 1.08
27 Vitamin D and cardiovascular disease. Nutrients 2013 1.07
28 Aldosterone and arterial hypertension. Nat Rev Endocrinol 2009 1.06
29 Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int 2012 1.05
30 Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Diabetes Care 2012 1.05
31 Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism 2013 1.04
32 Homoarginine, cardiovascular risk, and mortality. Circulation 2010 1.04
33 Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic women. Diabetes Care 2011 1.03
34 Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Am J Kidney Dis 2010 0.99
35 Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. Atherosclerosis 2011 0.99
36 Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 2011 0.96
37 Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie). Am J Kidney Dis 2011 0.96
38 Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Atherosclerosis 2012 0.95
39 Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. Eur Heart J 2012 0.93
40 Vitamin D and mortality: a Mendelian randomization study. Clin Chem 2013 0.93
41 Vitamin D supplementation and cancer: review of randomized controlled trials. Anticancer Agents Med Chem 2013 0.92
42 Comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-266. Diabetes Care 2013 0.91
43 Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality. Eur Heart J 2013 0.91
44 Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography. Eur J Heart Fail 2011 0.90
45 Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation 2015 0.88
46 The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women. Obesity (Silver Spring) 2011 0.88
47 Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. Eur Heart J 2011 0.88
48 Influence of resting heart rate on mortality in patients undergoing coronary angiography (from the Ludwigshafen Risk and Cardiovascular Health [LURIC] study). Am J Cardiol 2012 0.88
49 Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial. J Bone Miner Res 2009 0.87
50 Preatherosclerosis and adiponectin subfractions in obese adolescents. Obesity (Silver Spring) 2008 0.87
51 Vitamin D, arterial hypertension & cerebrovascular disease. Indian J Med Res 2013 0.87
52 Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis. Clin Chem Lab Med 2004 0.87
53 Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study. PLoS One 2013 0.86
54 Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles. Atherosclerosis 2008 0.86
55 Evaluation of risk profiles by subcutaneous adipose tissue topography in obese juveniles. Obesity (Silver Spring) 2007 0.85
56 Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus. Ther Drug Monit 2010 0.85
57 25-hydroxyvitamin D is not associated with carotid intima-media thickness in older men and women. Calcif Tissue Int 2009 0.85
58 Disease prevention: vitamin D trials. Science 2012 0.85
59 Calcium supplementation and vitamin D: a trigger for adverse cardiovascular events? Future Cardiol 2011 0.84
60 Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chem Lab Med 2012 0.83
61 Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial. BMC Endocr Disord 2012 0.83
62 Combination of low free testosterone and low vitamin D predicts mortality in older men referred for coronary angiography. Clin Endocrinol (Oxf) 2012 0.83
63 Low serum zinc levels in patients undergoing coronary angiography correlate with immune activation and inflammation. J Trace Elem Med Biol 2012 0.83
64 High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells. Eur J Nutr 2013 0.83
65 A closer look at evolution: Variants (SNPs) of genes involved in skin pigmentation, including EXOC2, TYR, TYRP1, and DCT, are associated with 25(OH)D serum concentration. Endocrinology 2015 0.82
66 Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium. Circ Cardiovasc Genet 2013 0.82
67 Aldosterone to active renin ratio is associated with nocturnal blood pressure in obese and treated hypertensive patients: the Styrian Hypertension Study. J Clin Hypertens (Greenwich) 2014 0.82
68 Association of 25-hydroxyvitamin D with type 2 diabetes among patients undergoing coronary angiography: cross-sectional findings from the LUdwigshafen Risk and Cardiovascular Health (LURIC) Study. Clin Endocrinol (Oxf) 2013 0.82
69 Effect of the resistin -420C > G polymorphism on cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2007 0.82
70 Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients. Eur Heart J 2012 0.81
71 Aldosterone and parathyroid hormone: a complex and clinically relevant relationship. Calcif Tissue Int 2010 0.81
72 Smoking, apolipoprotein E genotypes, and mortality (the Ludwigshafen RIsk and Cardiovascular Health study). Eur Heart J 2013 0.80
73 Cinacalcet hydrochloride for the treatment of hyperparathyroidism. Expert Opin Pharmacother 2013 0.80
74 Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients. Clin J Am Soc Nephrol 2013 0.80
75 Interplay between sodium and calcium regulatory hormones: a clinically relevant research field. Hypertension 2013 0.79
76 Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications. Clin Exp Hypertens 2014 0.78
77 Hyperglycaemia and vitamin D: a systematic overview. Curr Diabetes Rev 2012 0.78
78 Circulating aldosterone and mortality in female nursing home residents. Exp Gerontol 2013 0.78
79 Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patients. Nephron Clin Pract 2014 0.77
80 Homoarginine in patients with primary hyperparathyroidism. Am J Med Sci 2015 0.77
81 Vitamin D deficiency and stroke: time to act! Am J Cardiol 2010 0.77
82 Homoarginine, kidney function and cardiovascular mortality risk. Nephrol Dial Transplant 2014 0.77
83 Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial. J Hypertens 2016 0.77
84 Vitamin D deficiency and myocardial dysfunction. J Am Coll Cardiol 2009 0.76
85 Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality. J Am Geriatr Soc 2014 0.76
86 Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study. Transplantation 2015 0.76
87 Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients. Transplantation 2014 0.76
88 Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients. Clin Transplant 2013 0.76
89 Potential role of vitamin D deficiency on Fabry cardiomyopathy. J Inherit Metab Dis 2013 0.75
90 Vitamin D and arterial hypertension: treat the deficiency! Am J Hypertens 2012 0.75
91 Correspondence (letter to the editor): Appeal for vitamin D therapy. Dtsch Arztebl Int 2012 0.75
92 Author reply: To PMID 23021093. Ophthalmology 2013 0.75
93 Vitamin D status: to be considered in heart failure patients! Eur J Heart Fail 2011 0.75
94 Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients. Medicine (Baltimore) 2016 0.75
95 Eplerenone in mild heart failure. N Engl J Med 2011 0.75
96 Comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-266. Diabetes Care 2013 0.75
97 Circulating dopamine and C-peptide levels in fasting nondiabetic hypertensive patients: the Graz Endocrine Causes of Hypertension study. Diabetes Care 2012 0.75
98 Uric acid indicates a high cardiovascular risk profile but is not closely associated with insulin resistance in obese adolescents. Diabetes Care 2008 0.75
99 Hypoadiponectinemia as a risk factor for atherosclerosis? Stroke 2006 0.75
100 Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE. Ophthalmologica 2016 0.75
101 von Hippel-Lindau disease: treatment of retinal haemangioblastomas by targeted therapy with systemic bevacizumab. Acta Ophthalmol 2010 0.75
102 Vitamin D and cancer: current evidence and future perspective. Anticancer Agents Med Chem 2013 0.75
103 Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial. J Hypertens 2016 0.75
104 EXTEND II: an open-label phase III multicentre study to evaluate efficacy and safety of ranibizumab in Chinese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. BioDrugs 2014 0.75
105 Evaluation of 9 biomarkers for predicting 10-year cardiovascular risk in patients undergoing coronary angiography: findings from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study. Int J Cardiol 2013 0.75
106 [Vitamin D in Clinic and Practice]. Dtsch Med Wochenschr 2017 0.75